Clinical Trial Update: Safety and Efficacy of L. Lactis CKDB001 in Subjects With Early Alzheimer's Disease [NA]

View source ↗

Summary

This clinical trial is evaluating the safety and efficacy of the probiotic Lactococcus lactis CKDB001 in individuals with early Alzheimer's disease; recruitment…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Lactococcus lactis CKDB001 (Lactococcus lactis CKDB001)

Snippet

Sponsor: CKD Bio Corporation | Conditions: Early Alzheimers Disease | NA | Status: RECRUITING